Eiji Toyoda

N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma

Sanae Nakajima, Ryuichiro Doi, Eiji Toyoda et al. · Clinical Cancer Research · 2004 · 427 citations · Full text

Medicine, Cell Biology, Oncology +17

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

Tomohiko Mori, Ryuichiro Doi, Masayuki Koizumi et al. · Molecular Cancer Therapeutics · 2004 · 407 citations · Full text

Medicine, Oncology, Pharmacology +17

Metastin and its variant forms suppress migration of pancreatic cancer cells

Toshihiko Masui, Ryuichiro Doi, Tomohiko Mori et al. · Biochemical and Biophysical Research Communications · 2004 · 136 citations

Medicine, Cancer Biology, Oncology +14

RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

Toshihiko Masui, Ryuichiro Doi, Takatomo Koshiba et al. · PubMed · 2003 · 128 citations

Medicine, Oncology, Pathology +17

<i>In vivo</i> antitumor effect of the mTOR inhibitor CCI‐779 and gemcitabine in xenograft models of human pancreatic cancer

Daisuke Ito, Koji Fujimoto, Tomohiko Mori et al. · International Journal of Cancer · 2005 · 116 citations

Medicine, Oncology, Pharmacology +17